AIM
AIM ImmunoTech
15 hedge funds and large institutions have $1.4M invested in AIM ImmunoTech in 2015 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
Holders
15
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$38.3K | |
| 2 | +$26K | |
| 3 | +$6K | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$3K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$3K |
Top Sellers
| 1 | -$8.52K | |
| 2 | -$7K | |
| 3 | -$6K | |
| 4 |
Goldman Sachs
New York
|
-$5K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$2K |